Filing Details
- Accession Number:
- 0001140361-16-060931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-12 17:10:53
- Reporting Period:
- 2016-04-12
- Filing Date:
- 2016-04-12
- Accepted Time:
- 2016-04-12 17:10:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636282 | Aeglea Biotherapeutics Inc. | AGLE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532219 | Anthony Quinn | C/O Aeglea Biotherapeutics, Inc. 901 S. Mopac Expressway, Suite 250 Austin TX 78746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-12 | 10,000 | $10.00 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
